International advisory board

The International Advisory Board (IAB) consists of 6-8 international members covering a broad scientific field. The committee oversees and advises on the programme development and ensures that the research projects, fellows and mentors are of excellent, international standard. The board is overseen by the Programme Chair.

IAB supervises the progress and quality of the programme and provides guidelines and inspiration for further development.

IAB guides the programme in achieving its goal of training translational investigators, advises on the strategy of the programme, and provides an international perspective on current directions in translational science and innovative training methods.

Members

Alan Moses (chair)

Former Global Chief Medical Officer and Professor Emeritus, Novo Nordisk A/S and Harvard University

Hans Bräuner

Professor, Vice-Dean for Research, Faculty of Health and Medical Sciences, University of Copenhagen

Marlys Koschinsky

Scientific and Executive Director and Professor, Robarts Research Institute and Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry

Peter Garred

Professor, Department of Clinical Immunology, Rigshospitalet and Department of Clinical Medicine, University of Copenhagen

Susan A. Slaugenhaupt

Scientific Director, Mass General Reserach Institute, Massachusetts General Hospital

Clare Balendran

Vice President of Precision Medicine, Biomarkers and Diagnostics, Novo Nordisk A/S

Kristian Helin

Professor, Chief Executive and President of The Institute of Cancer Research, London, and BRIC, University of Copenhagen

Paul Conlin

Director, Professor and Chief of Medical Service, Clinical and Translational (C/T) Research Academy for Harvard Catalyst, Harvard Medical School, and VA Boston Healthcare System

Rasmus Møgelvang

Hospital Director, Rigshospitalet